drugset / Trial / NCT07351903
A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
Phase 1
Recruiting
15 enrolled
Tianjin Medical University Cancer Institute and Hospital
Beijing Geekgene Technology Co., LTD · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is an open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.
Timeline
- Start
- 2025-10-16
- Primary completion
- 2028-10-15
- Completion
- 2029-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GK01 | Cell therapy | — | — |